Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma

Phase 2

Recruiting

Conditions: Hypopharyngeal Cancer
Laryngeal Cancer

Interventions: Drug: Toripalimab

First Posted Date: 2022-06-15

Last Posted Date: 2022-06-15

Lead Sponsor: Fudan University

Target Recruit Count: 61

Registration Number: NCT05420597

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer

Not Applicable

Conditions: Non-small Cell Lung Cancer Metastatic

Interventions: Combination Product: bevacizumab plus nab-paclitaxel and platinum

First Posted Date: 2022-06-07

Last Posted Date: 2022-06-07

Lead Sponsor: Fudan University

Target Recruit Count: 56

Registration Number: NCT05407155

Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery

Not Applicable

Completed

Conditions: Mammary Cancer
PONV

Interventions: Device: electric stimulation therapy

First Posted Date: 2022-06-07

Last Posted Date: 2023-09-26

Lead Sponsor: Fudan University

Target Recruit Count: 198

Registration Number: NCT05408676

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis

Phase 2

Recruiting

Conditions: Melanoma

Interventions: Drug: Tislelizumab
Drug: Lenvatinib
Drug: Cryoablation

First Posted Date: 2022-06-06

Last Posted Date: 2022-11-10

Lead Sponsor: Fudan University

Target Recruit Count: 25

Registration Number: NCT05406466

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer

Phase 2

Not yet recruiting

Conditions: Breast Neoplasms
Locally Advanced or Metastatic Breast Cancer

Interventions: Drug: utidelone

First Posted Date: 2022-06-03

Last Posted Date: 2022-06-03

Lead Sponsor: Fudan University

Target Recruit Count: 61

Registration Number: NCT05403333

Efficacy and Safety of T+A+RAD in HCC

Phase 2

Conditions: Hepatocellular Carcinoma

Interventions: Radiation: Multifocal Stereotactic Radiotherapy
Drug: Atezolizumab Injection [Tecentriq]
Drug: Bevacizumab

First Posted Date: 2022-05-31

Last Posted Date: 2022-05-31

Lead Sponsor: Fudan University

Target Recruit Count: 42

Registration Number: NCT05396937

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China

Detection and Analysis of MBC With Heterogeneous ER Expression

Completed

Conditions: Breast Cancer

First Posted Date: 2022-05-26

Last Posted Date: 2024-02-26

Lead Sponsor: Fudan University

Target Recruit Count: 51

Registration Number: NCT05392985

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Real-world Study of UTD1 in Chinese Advanced Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2022-05-23

Last Posted Date: 2024-02-26

Lead Sponsor: Fudan University

Target Recruit Count: 150

Registration Number: NCT05386511

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Sintilimab and Bevacizumab Biosimilar Combined With PLD in mTNBC

Phase 2

Recruiting

Conditions: Breast Cancer

Interventions: Drug: sintilimab
Drug: bevacizumab biosimilar
Drug: pegylated liposomal doxorubicin

First Posted Date: 2022-05-23

Last Posted Date: 2023-02-16

Lead Sponsor: Fudan University

Target Recruit Count: 41

Registration Number: NCT05386524

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Effect of FMD on Colorectal Cancer Patients

Not Applicable

Recruiting

Conditions: Colorectal Cancer
Fasting Mimicking Diet

Interventions: Other: Fasting mimicking diet

First Posted Date: 2022-05-20

Last Posted Date: 2024-01-05

Lead Sponsor: Fudan University

Target Recruit Count: 602

Registration Number: NCT05384444

Locations: 🇨🇳
Shanghai First People's Hospital,Shanghai Jiaotong University, Shanghai, Shanghai, China
🇨🇳
Shanghai Changhai Hospital, Naval Medical University,, Shanghai, Shanghai, China
🇨🇳
Fudan University,ZhongShan Hospital, Shanghai, Shanghai, China

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy